Your browser doesn't support javascript.
loading
Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 study.
Goey, K K H; Elias, S G; van Tinteren, H; Laclé, M M; Willems, S M; Offerhaus, G J A; de Leng, W W J; Strengman, E; Ten Tije, A J; Creemers, G-J M; van der Velden, A; de Jongh, F E; Erdkamp, F L G; Tanis, B C; Punt, C J A; Koopman, M.
Afiliação
  • Goey KKH; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht.
  • Elias SG; Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht.
  • van Tinteren H; Department of Biometrics, Netherlands Cancer Institute Amsterdam - Antoni van Leeuwenhoek Hospital, Amsterdam.
  • Laclé MM; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht.
  • Willems SM; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht.
  • Offerhaus GJA; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht.
  • de Leng WWJ; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht.
  • Strengman E; Department of Pathology, University Medical Center Utrecht, Utrecht University, Utrecht.
  • Ten Tije AJ; Department of Medical Oncology, Amphia Hospital, Breda.
  • Creemers GM; Department of Medical Oncology, Catharina Hospital, Eindhoven.
  • van der Velden A; Department of Medical Oncology, Tergooi Hospital, Hilversum.
  • de Jongh FE; Department of Medical Oncology, Ikazia Hospital, Rotterdam.
  • Erdkamp FLG; Department of Medical Oncology, Zuyderland MC, Heerlen-Sittard.
  • Tanis BC; Department of Medical Oncology, Groene Hart Hospital, Gouda.
  • Punt CJA; Department of Medical Oncology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
  • Koopman M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht.
Ann Oncol ; 28(9): 2128-2134, 2017 Sep 01.
Article em En | MEDLINE | ID: mdl-28911067
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Capecitabina / Bevacizumab Tipo de estudo: Clinical_trials Aspecto: Patient_preference Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Capecitabina / Bevacizumab Tipo de estudo: Clinical_trials Aspecto: Patient_preference Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Ano de publicação: 2017 Tipo de documento: Article